OBJECTIVE-Central neural insulin regulates glucose homeostasis, but less is known about its cardiovascular effects. Endothelial nitric oxide synthase (eNOS)-derived nitric oxide (NO) represents a molecular link between metabolic and cardiovascular disease. Its role in the central nervous system remains to be determined. We studied the effects of central insulin infusion on femoral arterial blood flow and heart rate in normal chow-fed, high-fat diet-fed diabetic, and eNOS-null mice.RESEARCH DESIGN AND METHODS -We recorded heart rate and femoral blood flow (ultrasonic flow probe) during 3-h central insulin infusion in conscious, freely moving mice. To study the role of NO in this setting, we assessed total and phosphorylated eNOS in the hypothalamus and examined the effects of brain infusion of NO donors/NOS inhibitors on cardiovascular responsiveness to central insulin in these experimental mouse models.RESULTS -In normal mice, central insulin rapidly increased heart rate by 30% and more progressively increased blood flow by 40%. In high-fat diet-fed mice, the cardiovascular effects of insulin were blunted and associated with a 50% reduction of the total and phosphorylated eNOS expression in the hypothalamus, suggesting a causal link. In line with this hypothesis, in eNOS-null mice and central N G -monomethyl-L-arginine-infused normal mice, the cardiovascular effects of insulin were abolished, whereas central NO donor infusion restored these effects in eNOS-null mice. In high-fat diet-fed mice, central NO donor infusion mimicked the cardiovascular responses evoked by central insulin in normal mice. T here is now compelling evidence supporting the interplay between metabolic and vascular diseases (1,2). One hormonal and molecular regulatory mechanism common to both diseases is insulin-regulated nitric oxide (NO) synthase. For example, in skeletal muscle tissue, the endothelial form of NO synthase (eNOS) plays an important role in the intrinsic regulation of insulin-stimulated glucose uptake in vitro and in the regulation of blood flow and substrate delivery during hyperinsulinemic clamp studies in vivo (3). In line with this concept, we and others have shown that in mice, the ablation of the eNOS gene leads to hypertension and insulin resistance (3-6) and that insulin-regulated eNOS expression is an important feature of diabetes (5,6).
CONCLUSIONS -CentralIn addition to these peripheral actions, insulin is also a strong activator of the sympathetic autonomic nervous system (ANS) (7,8). Using intracerebroventricular (icv) administration of insulin, several studies have shown that the hypothalamus is the main regulatory center of the activity of the ANS (9 -11) with strong metabolic consequences (12,13,18). Besides its central function in the regulation of energy metabolism, the ANS could also play a role in the regulation of the short-and long-term adjustments of the vascular system during insulin administration. Interestingly, there is increasing evidence that NO is one of the major molecular regulators of central...